September 5, 2019
RegMed Investors’ (RMi) closing bell: from a negative open to a positive close
September 3, 2019
RegMed Investors’ (RMi) closing bell: Cell and gene therapy equities fell, the first trading day of a historically tough month
August 30, 2019
RegMed Investors’ (RMi) closing bell: the week and August – they’re over
August 29, 2019
RegMed Investors’ (RMi) closing bell: surging sector but, expect the rush upside to subside
August 28, 2019
RegMed Investors’ (RMi) closing bell: as we move through the market’s grounds
August 27, 2019
RegMed Investors’ (RMi) closing bell: when one side of the seesaw empties, the other drops like a stone
August 26, 2019
RegMed Investors’ (RMi) closing bell: the sector in relation to this market, optimism, hesitancy or fatalism, I’m split
August 25, 2019
RegMed Investors’ (RMi) Friday’s closing bell: another sector goose egg of a session
August 22, 2019
RegMed Investors’ (RMi) closing bell: short-term fear has battered the cell and gene therapy sector
August 21, 2019
RegMed Investors’ (RMi) closing bell: another high after a dive
August 20, 2019
RegMed Investors’ (RMi) closing bell: the sector dike sprung a leak and equities poured-out
August 19, 2019
RegMed Investors’ (RMi) closing bell: the sector rallied
August 16, 2019
RegMed Investors’ (RMi) closing bell: a whacky week as the volatility index of 19.13, -2.71 or -12.80%
August 15, 2019
RegMed Investors’ (RMi) closing bell: swing low, not so sweet chariot of equities
August 14, 2019
RegMed Investors’ (RMi) closing bell: another session of swimming with sharks
August 13, 2019
RegMed Investors’ (RMi) closing bell: the sector flipped up but, didn’t soar
August 12, 2019
RegMed Investors’ (RMi) closing bell: another expected spiral
August 10, 2019
RegMed Investors’ (RMi) closing bell: after the sessions and week’s numbers, there’s still a directional signal for the new periods coming
August 8, 2019
RegMed Investors’ (RMi) closing bell: the daily dose of share pricing
August 7, 2019
RegMed Investors’ (RMi) closing bell: the share pricing merry-go-round keeps spinning
August 6, 2019
RegMed Investors’ (RMi) closing bell: the sector recuperated after a bad session
August 5, 2019
RegMed Investors’ (RMi) closing bell: another wipe-out of sector value
August 2, 2019
RegMed Investors’ (RMi) closing bell: the session and the week’s review
August 1, 2019
RegMed Investors’ (RMi) closing bell: which company’s losses are lagging estimates?
July 31, 2019
RegMed Investors’ (RMi) closing bell: a breakdown of pricing as earnings’ season ramps-up
7 hours 37 min ago
RegMed Investors’ (RMi) pre-open: after standing tall, futures bend over
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his thirteenth (13th) year at RegMed Investors
© 2019 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.